Bumper Offer - Urjas oil Just @ Rs. 1
Derinide 0.5 Respules 2ml (7) is a prescription drug, available for use as Respules. It is typically used for the treatment of Asthma, Ulcerative Colitis. Secondary and off-label uses of Derinide 0.5 Respules 2ml (7) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Derinide 0.5 Respules 2ml (7). The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Derinide 0.5 Respules 2ml (7) side effects, there are can be others also. These have been listed below. Usually, these side effects of Derinide 0.5 Respules 2ml (7) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Derinide 0.5 Respules 2ml (7)'s effect during pregnancy is Safe and Severe while nursing. In addition, Derinide 0.5 Respules 2ml (7)'s effects on the liver, heart and kidney are discussed below in the Derinide 0.5 Respules 2ml (7) related warnings section.
Other contraindications of Derinide 0.5 Respules 2ml (7) have been discussed in the sections ahead.
Drug interactions for Derinide 0.5 Respules 2ml (7) have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Derinide 0.5 Respules 2ml (7) is safe while driving, and is addiction.
Derinide 0.5 Respules 2ml (7) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Derinide 0.5 Respules 2ml (7) is used -
Severe
Moderate
Mild
Is the use of Derinide 0.5 Respules 2ml (7) safe for pregnant women?
There are no side effects of Derinide in pregnant women.
Is the use of Derinide 0.5 Respules 2ml (7) safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Derinide. So it is adviced to consult the doctor before using it.
What is the effect of Derinide 0.5 Respules 2ml (7) on the Kidneys?
Derinide may have mild side effects on the kidneys.
What is the effect of Derinide 0.5 Respules 2ml (7) on the Liver?
Derinide is rarely harmful for the liver.
What is the effect of Derinide 0.5 Respules 2ml (7) on the Heart?
Derinide has very mild side effects on the heart.
Derinide 0.5 Respules 2ml (7) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Derinide 0.5 Respules 2ml (7) unless your doctor advises you to do so -
Is this Derinide 0.5 Respules 2ml (7) habit forming or addictive?
Derinide 0.5 Respules 2ml (7) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Derinide 0.5 Respules 2ml (7) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Derinide 0.5 Respules 2ml (7) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Derinide 0.5 Respules 2ml (7) is not used to treat mental disorders.
Interaction between Food and Derinide 0.5 Respules 2ml (7)
Due to a lack of research, nothing can be said about the consequences of taking Derinide 0.5 Respules 2ml (7) together with food.
Interaction between Alcohol and Derinide 0.5 Respules 2ml (7)
Due to lack of research, there is no information about the side effects of taking Derinide 0.5 Respules 2ml (7) with alcohol.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
